New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs.

Por Choe, Charles, Edelman, Steve
Publicado em 2007

Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study

Por Stauder, Udo, Enginee, Diplom, Elton, Hina, Penfornis, Alfred, Edelman, Steve
Publicado no J Diabetes Sci Technol (2014)

Impact of Biosimilar Insulins on Clinical Practice: Meeting Report

Por Dolinar, Richard O., Edelman, Steve, Heinemann, Lutz, Home, Philip, Goyal, Shefali, Polonsky, William H., Schellekens, Huub
Publicado no J Diabetes Sci Technol (2014)

Temporal Intra-Individual Variation of Immunological Biomarkers in Type 1 Diabetes Patients: Implications for Future Use in Cross-Sectional Assessment

Por Sarikonda, Ghanashyam, Pettus, Jeremy, Sachithanantham, Sowbarnika, Phatak, Sonal, Miller, Jacqueline F., Ganesan, Lakshmi, Chae, Ji, Mallios, Ronna, Edelman, Steve, Peters, Bjoern, von Herrath, Matthias
Publicado em 2013